Inspire Medical Systems, Inc. $INSP Shares Sold by Keybank National Association OH

Keybank National Association OH decreased its stake in shares of Inspire Medical Systems, Inc. (NYSE:INSP) by 0.2% during the second quarter, HoldingsChannel.com reports. The institutional investor owned 200,631 shares of the company’s stock after selling 439 shares during the quarter. Keybank National Association OH’s holdings in Inspire Medical Systems were worth $26,036,000 at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in INSP. GAMMA Investing LLC lifted its position in Inspire Medical Systems by 253.7% during the first quarter. GAMMA Investing LLC now owns 573 shares of the company’s stock worth $91,000 after buying an additional 411 shares in the last quarter. New York State Teachers Retirement System increased its stake in Inspire Medical Systems by 132.7% during the first quarter. New York State Teachers Retirement System now owns 21,390 shares of the company’s stock worth $3,407,000 after acquiring an additional 12,196 shares during the last quarter. WCM Investment Management LLC increased its position in shares of Inspire Medical Systems by 30.7% during the first quarter. WCM Investment Management LLC now owns 72,860 shares of the company’s stock valued at $11,457,000 after acquiring an additional 17,125 shares during the last quarter. Principal Financial Group Inc. increased its position in shares of Inspire Medical Systems by 1.0% during the first quarter. Principal Financial Group Inc. now owns 147,768 shares of the company’s stock valued at $23,536,000 after acquiring an additional 1,458 shares during the last quarter. Finally, Envestnet Asset Management Inc. increased its position in shares of Inspire Medical Systems by 33.1% during the first quarter. Envestnet Asset Management Inc. now owns 34,151 shares of the company’s stock valued at $5,440,000 after acquiring an additional 8,484 shares during the last quarter. Hedge funds and other institutional investors own 94.91% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages have recently weighed in on INSP. Jefferies Financial Group reaffirmed a “hold” rating and issued a $85.00 price objective (down from $160.00) on shares of Inspire Medical Systems in a research note on Friday, October 24th. Wall Street Zen cut Inspire Medical Systems from a “buy” rating to a “hold” rating in a research note on Saturday, July 26th. Zacks Research raised Inspire Medical Systems from a “strong sell” rating to a “hold” rating in a research note on Monday. Truist Financial decreased their price target on shares of Inspire Medical Systems from $125.00 to $90.00 and set a “hold” rating for the company in a research note on Wednesday, October 15th. Finally, Wells Fargo & Company decreased their price target on shares of Inspire Medical Systems from $174.00 to $101.00 and set an “equal weight” rating for the company in a research note on Tuesday, August 5th. Seven equities research analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat, Inspire Medical Systems presently has an average rating of “Hold” and an average target price of $141.13.

Inspire Medical Systems Stock Down 2.8%

NYSE:INSP opened at $73.03 on Friday. The stock’s 50 day moving average price is $81.23 and its 200 day moving average price is $114.43. The company has a market capitalization of $2.16 billion, a PE ratio of 42.22, a P/E/G ratio of 2.33 and a beta of 1.16. Inspire Medical Systems, Inc. has a 52-week low of $70.77 and a 52-week high of $216.01.

Inspire Medical Systems (NYSE:INSP) last released its quarterly earnings results on Monday, August 4th. The company reported $0.45 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.22 by $0.23. The firm had revenue of $217.09 million for the quarter, compared to the consensus estimate of $214.50 million. Inspire Medical Systems had a return on equity of 10.38% and a net margin of 6.17%.The firm’s quarterly revenue was up 10.8% compared to the same quarter last year. During the same quarter last year, the business posted $0.32 EPS. Inspire Medical Systems has set its FY 2025 guidance at 0.400-0.500 EPS. As a group, sell-side analysts anticipate that Inspire Medical Systems, Inc. will post 2.16 EPS for the current fiscal year.

Inspire Medical Systems declared that its board has initiated a share repurchase program on Monday, August 11th that permits the company to buyback $200.00 million in outstanding shares. This buyback authorization permits the company to buy up to 8.6% of its stock through open market purchases. Stock buyback programs are often a sign that the company’s leadership believes its stock is undervalued.

Insider Transactions at Inspire Medical Systems

In related news, CFO Richard Buchholz sold 11,000 shares of the firm’s stock in a transaction that occurred on Friday, August 29th. The stock was sold at an average price of $93.39, for a total transaction of $1,027,290.00. Following the transaction, the chief financial officer owned 44,867 shares in the company, valued at $4,190,129.13. This trade represents a 19.69% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. 4.10% of the stock is owned by corporate insiders.

Inspire Medical Systems Profile

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.